GPT Healthcare Limited Board Approves FY26 Results, Recommends 15% Dividend
GPT Healthcare Limited announced key decisions following its Board of Directors meeting held on May 18, 2026. The Board approved the audited financial results for the 4th quarter and the financial year ended March 31, 2026. The company also recommended a Final Dividend and approved matters pertaining to the upcoming Annual General Meeting (AGM).The Board confirmed that the Statutory Auditors, S R Batliboi & Co LLP, issued an audit report with an unmodified opinion on the audited financial results for the year ended March 31, 2026.
Dividend Recommendation and AGM Details
The Board recommended a Final Dividend of 15%, equating to ₹ 1.50 per equity share, for the financial year ended March 31, 2026. This dividend payment is subject to the approval of the shareholders at the 37th Annual General Meeting (AGM).The 37th AGM is scheduled to be held on Thursday, August 6, 2026, via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company approved book closure for this purpose from July 31, 2026, to August 6, 2026. The record date for determining the dividend entitlement for the financial year ended March 31, 2026, is set as July 30, 2026.
Corporate Governance Appointments
The Board approved several key appointments and continuous directorships, all subject to shareholder approval at the ensuing 37th AGM:- Statutory and Internal Auditors: S.K. Sahu & Associates was reappointed as the Cost Auditors of the Company for the Financial Year 2026-27. Additionally, RSM Astute Consulting Private Limited and ARVS & Associates, Chartered Accountants were reappointed as Internal Auditors for the same period.
- Independent Directors: Mr. Hari Modi and Dr. Tapti Sen were approved for re-appointment as Independent Directors for a second term of five years, commencing from September 15, 2026, and continuing up to September 14, 2031.
- Directorship Continuation: The continuation of the directorship of Mr. Amrendra Prasad Verma as a Non-Executive Independent Director, even after attaining 75 years of age on December 29, 2026, was approved.
- Remuneration: Increases in remuneration were approved for Dr. Mridul Tantia (Vice President) and Dr. Niharika Tantia (Consultant). The approval of professional fees for Dr. Ghanshyam Goyal, Non-Executive Non Independent Director, was also sanctioned.
Financial Performance Summary
The detailed financial statements reflect the company's operations. Below are the key financial results for the respective periods:Statement of Audited Financial Results (Amounts in lakhs, unless otherwise stated):
| Particulars | Quarter Ended 31.03.2026 (Audited) | Quarter Ended 31.12.25 (Unaudited) | Quarter Ended 31.03.25 (Audited) | Year Ended 31.03.26 | Year Ended 31.03.25 |
|---|---|---|---|---|---|
| Revenue from operations | 12,637.18 | 12,058.6 | 10,140.22 | 47,254.70 | 40,709.14 |
| Other income | 162.84 | 142.16 | 157.29 | 595.12 | 849.43 |
| Total income | 72,800.02 | 12,158.02 | 10,297.51 | 47,849.82 | 41,558.57 |
| Total Expenses | 71,213.54 | 10,882.25 | 8,660.62 | 42,369.27 | 34,624.01 |
| Profit before tax | 1,586.48 | 1,275.77 | 1,636.89 | 5,480.55 | 6,934.56 |
| Profit after tax | 1,456.60 | 936.83 | 1,289.00 | 4,272.05 | 4,992.17 |
| Total Comprehensive income | 1,447.23 | 935.64 | 1,306.93 | 4,209.11 | 4,987.40 |
| Basic Earnings per share (of 10 each) | 178 | 114 | 157 | 5.15 | 6.08 |
Statement of Audited Assets and Liabilities (Amounts in lakhs):
| Particulars | As at 31, 2026 (Audited) | As at March 31, 2025 (Audited) |
|---|---|---|
| ASSETS | ||
| Property, Plant and Equipment | 26,544.37 | 20,255.98 |
| Total Non-Current Assets | 37,546.90 | 30,543.73 |
| Inventories | 1,060.09 | 832.50 |
| Investments | 4,293.58 | 3,198.03 |
| Trade receivable | 2,008.42 | 1,969.90 |
| Cash and cash equivalents | 413.32 | 165.88 |
| Total Current Assets | 8,927.92 | 7,881.61 |
| Total Assets | 46,474.82 | 38,425.34 |
| EQUITY AND LIABILITIES | ||
| Other Equity | 18,737.32 | 16,579.58 |
| Total Equity | 26,942.80 | 74,785.06 |
| Total Non-current Liabilities | 11,582.59 | 6,215.96 |
| Total Current Liabilities | 7,949.43 | 7,424.32 |
| Total Equity & Liabilities | 46,474.82 | 38,425.34 |
Statement of Audited Cash Flows (Amounts in lakhs):
| Particulars | For the year ended March 31, 2026 (Audited) | For the year ended March 31, 2025 (Audited) |
|---|---|---|
| CASH FLOW FROM OPERATING ACTIVITIES | ||
| Profit Before Tax | 5,480.55 | 6,934.56 |
| Cash Generated from operations before working capital changes | 8,868.84 | 8,808.63 |
| Cash Generated from Operations | 9,418.94 | 8,447.70 |
| Net Cash generated from Operating Activities | 8,116.10 | 6,739.61 |
| CASH FLOW FROM INVESTING ACTIVITIES | ||
| Net Cash used in Investing Activities | (4,725.23) | (3,259.17) |
| CASH FLOW FROM FINANCING ACTIVITIES | ||
| Net Cash used in Financing Activities | (3,143.43) | (3,483.88) |
| Net increase/(decrease) in Cash & Cash Equivalent | 247.44 | (3.44) |
| Cash & Cash Equivalents at the beginning of the year | 165.88 | 169.32 |
| Cash & Cash Equivalents at the end of the year | 413.32 | 165.88 |
GPTHEALTH Stock Price Movement
GPT Healthcare Limited shares today slipped by 1.11% to settle at ₹138.76. Trading volume totaled 77,663 shares, while the stock found support within an intraday range of ₹137.5 to ₹141.75.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.